Partnering & Outsourcing Editorial

31. Mimicking The Hollywood Mindset To Develop Drugs In An Era Driven By Capital Markets 11/7/2024

    Traditional organizational structures often struggle to adapt to the dynamic nature of drug development; consultant Sid Parulkar offers another approach that borrows from the Hollywood film industry.

32. As The Pendulum Swings, More Sponsors Initiate Site Identification And Feasibility 10/25/2024

    Consultant Megan Liles has seen outsourcing shifts over the years but says this one feels different. Here, Liles explains why she believes sponsors will ultimately initiate site identification and feasibility before bringing a CRO on board.

33. Panavance Details IND Prep Ahead Of FDA Submission For Ovarian Cancer Trial 10/23/2024

    Panavance CEO Greg Bosch discusses the company’s pursuit of a second trial for misetionamide, walking us through IND preparations, CRO selection, and securing funding. 

34. The Role Of The CRO Is Changing. Why? 10/21/2024

    The role of the CRO is in flux. As sponsors shift to full-service outsourced (FSO) models to functional service provider (FSP) models, CROs are finding themselves redefining their role in the outsourcing relationship. Jeremy Weitz explains in this two-part series. on the changing role of the CRO.

35. With The Rise Of PAOs And Site Networks, What Will The CRO's Role Be? 10/21/2024

    In part two of this series, Jeremy Weitz discusses the roles of PAOs and site networks, as well as how CROs are partnering with them, and predicts how CROs might reinvent themselves. 

36. Why Site-CRO Relationships Are So Strained — And How To Fix Them 10/18/2024

    Empactful Ventures Founder Denise Bronner explains the issues that strain site-sponsor relationships and how to resolve them.

37. A New Barometer For Clinical Outsourcing Performance 10/16/2024

    Interested in how some of the top publicly traded clinical development outsourcing companies are doing in the market? Andrew Schafer may be able to help with his Schafer Clinical Development Index (SCDI).

38. The Value Of A High-Performing Regulatory Function Within A CRO 9/25/2024

    Consultant Pete Embley discusses the value a regulatory expert brings to both CROs and sponsors alike.

39. Clinical Development Negotiation: How Can A Notebook, Chronodex, And Compendium Help Enhance Partnerships? 9/12/2024

    What can three tools — a notebook, a chronodex, and a compendium — teach clinical research professionals about successful negotiation and collaboration? RHIEOS-Ventures and Dealligence's Larry Ajuwon explains.

40. Dedicated Trialist, Nurse Navigators Help Advance Cancer Therapy Into Accelerated Approval 9/11/2024

    Thoracic medical oncologist Sally Lau, MD Lau discusses her role as a principal investigator, from the benefits of the FDA’s accelerated approval pathway to best practices for retaining a challenging patient population.